GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mangoceuticals MGRX · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.20

+1.08%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$456,021

FY2021FY2025

Net income

−$20.6m

FY2021FY2025

Free cash flow

−$5.9m

FY2021FY2025

Shareholders' equity

$15.2m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Revenue$456,021$615,873$731,493$8,939—
Gross profit$250,386$379,964$431,501$4,850—
Operating income−$20.5m−$8.7m−$9.2m−$2.0m−$17,520
Net income−$20.6m−$8.7m−$9.2m−$2.0m−$17,701
Diluted earnings per share-1.30-2.68-6.45-1.73-0.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assets$16.1m$15.4m$1.1m$1.0m$22,550
Cash and short-term investments$1.5m$58,653$739,006$682,860$22,550
Total liabilities$890,568$1.4m$276,039$389,257$39,270
Debt$307,823$214,962$128,679$352,865$39,270
Shareholders' equity$15.2m$13.9m$774,754$614,030−$16,720
Shares outstanding16m3m1m1m1m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations−$5.9m−$4.9m−$7.0m−$1.3m−$17,520
Capital spending−$5—−$3,519−$43,102−$43,102
Free cash flow−$5.9m−$4.9m−$7.0m−$1.4m−$60,622
Dividends paid—−$802,109———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$68,757$67,864$94,360$84,246$168,109$109,306$105,247$133,368
Gross profit$44,215$29,000$47,475$50,899$89,948$62,064$80,103$82,671
Operating income−$1.0m−$3.1m−$2.7m−$7.5m−$5.4m−$4.9m−$1.7m−$1.8m
Net income−$1.3m−$3.4m−$2.8m−$7.6m−$5.4m−$4.8m−$1.9m−$2.0m
Diluted earnings per share-0.08-0.20-0.17-0.48-0.34-0.30-0.60-0.62
Cash from operations—−$1.0m−$1.0m−$1.0m−$1.0m−$2.0m−$1.0m−$1.0m
Total assets$14.2m$14.4m$16.1m$16.5m$20.8m$21.8m$15.4m$14.8m
Cash and short-term investments$228,688$174,562—$481,281$101,019$76,496$58,653$73,912
Debt$73,245$57,058—$112,167$630,117$47,713$214,962$256,840
Shareholders' equity$12.5m$13.5m$15.2m$15.7m$19.2m$20.3m$13.9m$13.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue270.9%——
Operating income117.7%——
Net income117.8%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin58.8%58.9%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings-0.6-0.3-0.2
Price to sales25.84.12.6

Share price return

Finished calendar years

202520242023
Return-10%-42%-88%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-to-1 reverse split · 16 Oct 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.